VCNX Annual Cash & Cash Equivalents
$1.53 M
-$4.86 M-75.98%
31 December 2023
Summary:
As of January 20, 2025, VCNX annual cash & cash equivalents is $1.53 million, with the most recent change of -$4.86 million (-75.98%) on December 31, 2023. During the last 3 years, it has fallen by -$9.06 million (-85.51%). VCNX annual cash & cash equivalents is now -85.51% below its all-time high of $10.60 million, reached on December 31, 2020.VCNX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VCNX Quarterly Cash And Cash Equivalents
$2.91 M
+$2.67 M+1147.21%
30 September 2024
Summary:
As of January 20, 2025, VCNX quarterly cash and cash equivalents is $2.91 million, with the most recent change of +$2.67 million (+1147.21%) on September 30, 2024. Over the past year, it has dropped by -$66.00 thousand (-2.22%). VCNX quarterly cash and cash equivalents is now -90.11% below its all-time high of $29.39 million, reached on March 31, 2021.VCNX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VCNX Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -76.0% | -2.2% |
3 y3 years | -85.5% | -12.6% |
5 y5 years | -72.7% | -12.6% |
VCNX Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -82.1% | at low | -82.7% | +2188.2% |
5 y | 5-year | -85.5% | at low | -90.1% | +2188.2% |
alltime | all time | -85.5% | at low | -90.1% | +2188.2% |
Vaccinex Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $2.91 M(+1147.2%) |
June 2024 | - | $233.00 K(-92.2%) |
Mar 2024 | - | $2.97 M(+93.6%) |
Dec 2023 | $1.53 M(-76.0%) | $1.53 M(+1108.7%) |
Sept 2023 | - | $127.00 K(-93.3%) |
June 2023 | - | $1.91 M(-42.6%) |
Mar 2023 | - | $3.32 M(-48.0%) |
Dec 2022 | $6.39 M(-25.6%) | $6.39 M(-11.1%) |
Sept 2022 | - | $7.19 M(-37.0%) |
June 2022 | - | $11.40 M(-32.2%) |
Mar 2022 | - | $16.80 M(+95.6%) |
Dec 2021 | $8.59 M | $8.59 M(-37.5%) |
Sept 2021 | - | $13.74 M(-38.6%) |
June 2021 | - | $22.39 M(-23.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $29.39 M(+177.4%) |
Dec 2020 | $10.60 M(+281.7%) | $10.60 M(-38.0%) |
Sept 2020 | - | $17.09 M(+3149.4%) |
June 2020 | - | $526.00 K(-78.9%) |
Mar 2020 | - | $2.49 M(-10.3%) |
Dec 2019 | $2.78 M(-50.6%) | $2.78 M(-67.6%) |
Sept 2019 | - | $8.58 M(+62.5%) |
June 2019 | - | $5.28 M(-41.0%) |
Mar 2019 | - | $8.94 M(+59.2%) |
Dec 2018 | $5.62 M(+34.4%) | $5.62 M(-50.1%) |
Sept 2018 | - | $11.26 M(+767.3%) |
June 2018 | - | $1.30 M(-55.6%) |
Mar 2018 | - | $2.92 M(-30.0%) |
Dec 2017 | $4.18 M(+151.7%) | $4.18 M |
Dec 2016 | $1.66 M | - |
FAQ
- What is Vaccinex annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Vaccinex?
- What is Vaccinex annual cash & cash equivalents year-on-year change?
- What is Vaccinex quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Vaccinex?
- What is Vaccinex quarterly cash and cash equivalents year-on-year change?
What is Vaccinex annual cash & cash equivalents?
The current annual cash & cash equivalents of VCNX is $1.53 M
What is the all time high annual cash & cash equivalents for Vaccinex?
Vaccinex all-time high annual cash & cash equivalents is $10.60 M
What is Vaccinex annual cash & cash equivalents year-on-year change?
Over the past year, VCNX annual cash & cash equivalents has changed by -$4.86 M (-75.98%)
What is Vaccinex quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VCNX is $2.91 M
What is the all time high quarterly cash and cash equivalents for Vaccinex?
Vaccinex all-time high quarterly cash and cash equivalents is $29.39 M
What is Vaccinex quarterly cash and cash equivalents year-on-year change?
Over the past year, VCNX quarterly cash and cash equivalents has changed by -$66.00 K (-2.22%)